Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated Jun 22, 2021, titled "Sun Pharma Announces Settlement of Patent Litigation forGeneric Revlimid�� (lenalidomide) in US".
Press Release Jun 22 2021
Filed with NSE ·
6ix hasn’t read this filing yet.
Sun Pharmaceutical Industries Limited on 6ix
Earlier from Sun Pharmaceutical Industries
- Press Release Jun 02 2021
- Press Release May 27 2021
- Press Release May 12 2021
- Press Release May 10 2021
- Press Release Feb 25 2021
Later from Sun Pharmaceutical Industries
- Press Release Jun 29 2021
- Press Release Jul 01 2021
- Press Release Jul 16 2021
- Press Release Jul 26 2021
- Press Release Jul 30 2021
Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.
Follow Sun Pharmaceutical Industries